Eli Lilly, Sumitomo Dainippon sales and marketing update

Eli Lilly and Sumitomo Dainippon launched Trulicity dulaglutide in Japan to treat Type II diabetes. The companies are co-promoting the once-weekly, long-acting glucagon-like peptide-1 (GLP-1) recept...